Middle Aged Clinical Trial
Official title:
A Text- and Audio-based Intervention to Promote Physical Activity in Midlife
This is a randomized, controlled pilot trial (N=30) to examine the feasibility, acceptability, and preliminary efficacy of the Move with Meaning program, an 8- week, text message- and audio-based intervention to promote physical activity in midlife adults.
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | February 1, 2025 |
Est. primary completion date | February 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 45 Years to 64 Years |
Eligibility | Inclusion Criteria: - Midlife adults (aged 45-64 years at the time of enrollment) - Suboptimal physical activity (score < 6 on the Medical Outcomes Study Specific Adherence Scale physical activity item) - Access to a phone capable of receiving text messages and listening to audio files (i.e., a smartphone) Exclusion Criteria: - An unrelated condition limiting physical activity - Participation in any other programs focused on cardiac prevention or well-being - A cognitive disturbance precluding participation or informed consent - Current pregnancy - Inability to speak/write fluently in English |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of text message sessions successfully delivered | The automated platform will record rates of successful text message delivery. | Weekly over 8 weeks | |
Secondary | Proportion of audio sessions completed by participants | We will record the number of sessions in which participants engaged (e.g., responded to a text message), out of a total of 8 sessions. | Weekly over 8 weeks | |
Secondary | Session utility | Participants will rate the utility of each session, measured on a 10-point Likert scale. Higher scores indicate greater utility. | Weekly over 8 weeks | |
Secondary | Change in overall physical activity (in steps/day) | Physical activity (steps) will be measured via an Actigraph accelerometer. We will use established accelerometer protocols to measure the mean number of steps taken per day at each time point. | Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only) | |
Secondary | Change in moderate to vigorous physical activity (MVPA; in mean minutes/day) | MVPA (reported in mean minutes of MVPA/day) will be measured via an Actigraph accelerometer and recorded in mean minutes/day. | Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only) | |
Secondary | Change in sedentary time (in mean minutes/day) | Sedentary time (mean minutes/day) will be measured via Actigraph accelerometer. | Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only) | |
Secondary | Change in self-reported physical activity (International Physical Activity Questionnaire [IPAQ]; in metabolic equivalent-minutes/week) | This will be measured via the International Physical Activity Questionnaire (IPAQ) as a secondary measure of physical activity. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | |
Secondary | Change in positive affect (Positive and Negative Affect Schedule [PANAS] positive affect items) | Positive affect (our main psychological outcome given its links to health outcomes and sensitivity to change) will be assessed via the Positive and Negative Affect Schedule (PANAS) positive affect items. PANAS scores range from 10-50, with higher scores indicating higher levels of positive affect. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | |
Secondary | Change in optimism (Life Orientation Test - Revised [LOT-R]) | Optimism will be measured using the Life Orientation Test - Revised (LOT-R), a frequently used 6-item instrument that assesses dispositional optimism. LOT-R scores range from 0-24, with higher scores indicating higher levels of optimism. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | |
Secondary | Change in depressive symptoms (depression subscale of the Hospital Anxiety and Depression Scale [HADS]). | Depressive symptoms will be measured using the 7-item depression subscale of the Hospital Anxiety and Depression Scale (HADS). The depression subscale of the HADS ranges from 0-21, with higher scores indicating higher levels of depression. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | |
Secondary | Change in anxiety (anxiety subscale of the Hospital Anxiety and Depression Scale [HADS]) | Anxiety will be measured using the 7-item anxiety subscale of the Hospital Anxiety and Depression Scale (HADS). The anxiety subscale of the HADS ranges from 0-21, with higher scores indicating higher levels of anxiety. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | |
Secondary | Change in exercise self-efficacy (Self-Efficacy for Exercise scale [SEE]) | Exercise self-efficacy will be measured via the Self-Efficacy for Exercise (SEE) scale. SEE scores range from 0-90, with higher scores indicating higher levels of self-efficacy for exercise. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | |
Secondary | Change in perceived social support (Multidimensional Scale of Perceived Social Support) | Perceived social support will be measured by the Multidimensional Scale of Perceived Social Support (MSPSS). MSPSS scores range from 1-7, with higher scores indicating higher levels of perceived social support. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | |
Secondary | Change in internal health locus of control (Multidimensional Health Locus of Control [MHLC] scale) | Internal locus/sense of control will be measured using the Multidimensional Health Locus of Control (MHLC) scale. The internal locus of control score from the MHLC ranges from 6-36, with higher scores indicating greater internal locus of control. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | |
Secondary | Change in positive affect during activity (Physical Activity Enjoyment Scale) | Positive affect during activity will be measured using the Physical Activity Enjoyment Scale. Physical Activity Enjoyment Scale scores range from 18-126, with higher scores indicating higher levels of enjoyment during activity. | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05841667 -
Impact of CES1 Genotype on Remimazolam
|
||
Active, not recruiting |
NCT04849052 -
Text Messaging to Increase Activity in Midlife
|
Phase 1 | |
Completed |
NCT04745182 -
A Tailored Program to Promote Well-being and Physical Activity in Mid-life Adults With Low Physical Activity
|
N/A | |
Completed |
NCT05231564 -
Hybrid Training and Middle Age
|
N/A | |
Completed |
NCT05462977 -
Rhythmically Entrained Exercise in Community-Dwelling Older Adults
|
N/A | |
Completed |
NCT05163236 -
Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening
|